{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:02:25Z","timestamp":1789628545401,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Project on the Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2024GXNSFBA010303"],"award-info":[{"award-number":["2024GXNSFBA010303"]}]},{"name":"Youth Fund of Guangxi Natural Science Foundation","award":["2025GXNSFBA069015"],"award-info":[{"award-number":["2025GXNSFBA069015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10620-026-10182-7","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:46:58Z","timestamp":1787154418000},"page":"5948-5967","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HKDC1 as a Prognostic and Tumor Microenvironment\u2011Associated Biomarker in Colorectal Cancer: An Integrated Multi\u2011omics and Spatial Transcriptomic Study"],"prefix":"10.1007","volume":"71","author":[{"given":"Yuman","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kairan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqiao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongnan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"10182_CR1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/s0140-6736(25)01635-6","volume":"406","author":"LM Force","year":"2025","unstructured":"Force LM, Kocarnik JM, May ML, Bhangdia K, Crist A, Penberthy L, Pritchett N, Acheson A, Deitesfeld L, Aalruz H, Abbas N. The global, regional, and national burden of cancer, 1990\u20132023, with forecasts to 2050: a systematic analysis for the global burden of disease study 2023. Lancet 2025;406:1565\u20131586. https:\/\/doi.org\/10.1016\/s0140-6736(25)01635-6.","journal-title":"Lancet"},{"key":"10182_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics. CA: A Cancer J Clin 2025;75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA: A Cancer J Clin"},{"key":"10182_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li Q, Geng S, Luo H, Wang W, Mo Y-Q, Luo Q et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Trans Target Ther 2024;9:266. https:\/\/doi.org\/10.1038\/s41392-024-01953-7.","journal-title":"Signal Trans Target Ther"},{"key":"10182_CR4","doi-asserted-by":"publisher","first-page":"138849","DOI":"10.1016\/j.jcis.2025.138849","volume":"702","author":"J Lu","year":"2026","unstructured":"Lu J, Li Y, Qin X, Wang Z, Ouyang A, Su B et al. A clinically inspired olsalazine-based metal-organic framework enables a universal nanodrugs platform for diverse disease. J Colloid Interface Sci 2026;702:138849. https:\/\/doi.org\/10.1016\/j.jcis.2025.138849.","journal-title":"J Colloid Interface Sci"},{"key":"10182_CR5","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science 2020;368:eaaw5473. https:\/\/doi.org\/10.1126\/science.aaw5473.","journal-title":"Science"},{"key":"10182_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer 2016;16:635\u2013649. https:\/\/doi.org\/10.1038\/nrc.2016.77.","journal-title":"Nat Rev Cancer"},{"key":"10182_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13048-022-01027-8","volume":"15","author":"X Tian","year":"2022","unstructured":"Tian X, Liu D, Zuo X, Sun X, Wu M, Li X et al. Hexokinase 2 promoted cell motility and proliferation by activating Akt1\/p-Akt1 in human ovarian cancer cells. J Ovarian Res 2022;15:92. https:\/\/doi.org\/10.1186\/s13048-022-01027-8.","journal-title":"J Ovarian Res"},{"key":"10182_CR8","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/s41467-021-22163-7","volume":"12","author":"X Shangguan","year":"2021","unstructured":"Shangguan X, He J, Ma Z, Zhang W, Ji Y, Shen K et al. SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis. Nat Commun 2021;12:1812. https:\/\/doi.org\/10.1038\/s41467-021-22163-7.","journal-title":"Nat Commun"},{"key":"10182_CR9","doi-asserted-by":"publisher","first-page":"2105126","DOI":"10.1002\/advs.202105126","volume":"9","author":"H Li","year":"2022","unstructured":"Li H, Song J, He Y, Liu Y, Liu Z, Sun W et al. CRISPR\/Cas9 screens reveal that hexokinase 2 enhances cancer stemness and tumorigenicity by activating the ACSL4-Fatty Acid \u03b2-oxidation pathway. Adv Sci 2022;9:2105126. https:\/\/doi.org\/10.1002\/advs.202105126.","journal-title":"Adv Sci"},{"key":"10182_CR10","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.cmet.2024.10.002","volume":"36","author":"H Yan","year":"2024","unstructured":"Yan H, Wang Z, Teng D, Chen X, Zhu Z, Chen H et al. Hexokinase 2 senses fructose in tumor-associated macrophages to promote colorectal cancer growth. Cell Metabol 2024;36:2449-2467.e6. https:\/\/doi.org\/10.1016\/j.cmet.2024.10.002.","journal-title":"Cell Metabol"},{"key":"10182_CR11","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1038\/ncomms7069","volume":"6","author":"C Guo","year":"2015","unstructured":"Guo C, Ludvik AE, Arlotto ME, Hayes MG, Armstrong LL, Scholtens DM et al. Coordinated regulatory variation associated with gestational hyperglycaemia regulates expression of the novel hexokinase HKDC1. Nat Commun 2015;6:6069. https:\/\/doi.org\/10.1038\/ncomms7069.","journal-title":"Nat Commun"},{"key":"10182_CR12","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/hep.0000000000001085","volume":"81","author":"L Fan","year":"2025","unstructured":"Fan L, Tian C, Yang W, Liu X, Dhungana Y, Yang W et al. HKDC1 promotes liver cancer stemness under hypoxia through stabilizing \u03b2-catenin. Hepatology 2025;81:1685\u20131699. https:\/\/doi.org\/10.1097\/hep.0000000000001085.","journal-title":"Hepatology"},{"key":"10182_CR13","doi-asserted-by":"publisher","first-page":"58489","DOI":"10.1021\/acsami.4c15320","volume":"16","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Ouyang A, Fan L, Qin X, Li Y, Wang Z et al. Precision delivery of binary cooperative nanodrugs self-assembled by berberine glycyrrhetinic acid salts for hepatocellular carcinoma treatment. ACS Appl Mater Int 2024;16:58489\u201358505. https:\/\/doi.org\/10.1021\/acsami.4c15320.","journal-title":"ACS Appl Mater Int"},{"key":"10182_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/0109298665297110240611115010","volume":"31","author":"H Ge","year":"2024","unstructured":"Ge H, Yan Y, Wang H, Bian J, Deng Z, Su X et al. Circular RNA hsa_circ_0005939 regulates UHRF1BP1L expression by targeting miR-4693\u20133p to promote colorectal cancer progression. Protein Pept Lett 2024;31:437\u2013446. https:\/\/doi.org\/10.2174\/0109298665297110240611115010.","journal-title":"Protein Pept Lett"},{"key":"10182_CR15","doi-asserted-by":"publisher","first-page":"e150923221164","DOI":"10.2174\/1874467217666230915125622","volume":"17","author":"Y Ruan","year":"2024","unstructured":"Ruan Y, Lu G, Yu Y, Luo Y, Wu H, Shen Y et al. PF-04449913 inhibits proliferation and metastasis of colorectal cancer cells by down-regulating MMP9 expression through the ERK\/p65 pathway. Curr Mol Pharmacol 2024;17:e150923221164. https:\/\/doi.org\/10.2174\/1874467217666230915125622.","journal-title":"Curr Mol Pharmacol"},{"key":"10182_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2174\/0109298665305114240718072029","volume":"31","author":"S Tian","year":"2024","unstructured":"Tian S, Chen M, Jing W, Meng Q, Wu J. miR-1204 positioning in 8q24.21 involved in the tumorigenesis of colorectal cancer by targeting MASPIN. Protein Pept Lett 2024;31:544\u2013558. https:\/\/doi.org\/10.2174\/0109298665305114240718072029.","journal-title":"Protein Pept Lett"},{"key":"10182_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/0109298665248028231122064831","volume":"31","author":"Z Xu","year":"2024","unstructured":"Xu Z, Yu Y, Ni H, Sun W, Kuang Y. LINC01836 promotes colorectal cancer progression and functions as ceRNA to target SLC17A9 by sponging miR-1226\u20133p. Protein Pept Lett 2024;31:43\u201360. https:\/\/doi.org\/10.2174\/0109298665248028231122064831.","journal-title":"Protein Pept Lett"},{"key":"10182_CR18","doi-asserted-by":"publisher","first-page":"108478","DOI":"10.1016\/j.jbc.2025.108478","volume":"301","author":"S Huang","year":"2025","unstructured":"Huang S, Pang Q, Zhang Y, Cao J. HKDC1 promotes colorectal cancer progression by regulating RCOR1 expression to activate the Wnt\/beta-catenin pathway, enhancing proliferation, migration, and epithelial-mesenchymal transition. J Biol Chem 2025;301:108478. https:\/\/doi.org\/10.1016\/j.jbc.2025.108478.","journal-title":"J Biol Chem"},{"key":"10182_CR19","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/s1470-2045(21)00588-x","volume":"23","author":"C Eng","year":"2022","unstructured":"Eng C, J\u00e1come AA, Agarwal R, Hayat MH, Byndloss MX, Holowatyj AN et al. A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol 2022;23:e116\u2013e128. https:\/\/doi.org\/10.1016\/s1470-2045(21)00588-x.","journal-title":"Lancet Oncol"},{"key":"10182_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/s2468-1253(21)00426-x","volume":"7","author":"SG Patel","year":"2022","unstructured":"Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol 2022;7:262\u2013274. https:\/\/doi.org\/10.1016\/s2468-1253(21)00426-x.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10182_CR21","doi-asserted-by":"publisher","first-page":"n1855","DOI":"10.1136\/bmj.n1855","volume":"374","author":"P Kanth","year":"2021","unstructured":"Kanth P, Inadomi JM. Screening and prevention of colorectal cancer. Bmj 2021;374:n1855. https:\/\/doi.org\/10.1136\/bmj.n1855.","journal-title":"Bmj"},{"key":"10182_CR22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1101\/gad.348226.120","volume":"35","author":"J Li","year":"2021","unstructured":"Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA. Genetic and biological hallmarks of colorectal cancer. Genes Dev 2021;35:787\u2013820. https:\/\/doi.org\/10.1101\/gad.348226.120.","journal-title":"Genes Dev"},{"key":"10182_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00018-024-05491-x","volume":"81","author":"Z Fang","year":"2024","unstructured":"Fang Z, Zhang W, Wang H, Zhang C, Li J, Chen W et al. Helicobacter pylori promotes gastric cancer progression by activating the TGF-\u03b2\/Smad2\/EMT pathway through HKDC1. Cell Mol Life Sci 2024;81:453. https:\/\/doi.org\/10.1007\/s00018-024-05491-x.","journal-title":"Cell Mol Life Sci"},{"key":"10182_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41419-022-04999-z","volume":"13","author":"MW Khan","year":"2022","unstructured":"Khan MW, Terry AR, Priyadarshini M, Ilievski V, Farooq Z, Guzman G et al. The hexokinase \u201cHKDC1\u201d interaction with the mitochondria is essential for liver cancer progression. Cell Death Dis 2022;13:660. https:\/\/doi.org\/10.1038\/s41419-022-04999-z.","journal-title":"Cell Death Dis"},{"key":"10182_CR25","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/cas.15692","volume":"114","author":"MQ Wang","year":"2023","unstructured":"Wang MQ, Chen YR, Xu HW, Zhan JR, Suo DQ, Wang JJ et al. HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer. Cancer Sci 2023;114:1365\u20131377. https:\/\/doi.org\/10.1111\/cas.15692.","journal-title":"Cancer Sci"},{"key":"10182_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s42003-025-08031-w","volume":"8","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chen J, Wang Z, Luo X, Wu N, Wang J. HKDC1 promotes ovarian cancer progression through boosting lipid metabolism and immune escape by stabilizing G6PC\/G6PC2. Commun Biol 2025;8:615. https:\/\/doi.org\/10.1038\/s42003-025-08031-w.","journal-title":"Commun Biol"},{"key":"10182_CR27","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s41418-024-01392-5","volume":"31","author":"P Liu","year":"2024","unstructured":"Liu P, Luo Y, Wu H, Han Y, Wang S, Liu R et al. HKDC1 functions as a glucose sensor and promotes metabolic adaptation and cancer growth via interaction with PHB2. Cell Death Differ 2024;31:1595\u20131610. https:\/\/doi.org\/10.1038\/s41418-024-01392-5.","journal-title":"Cell Death Differ"},{"key":"10182_CR28","doi-asserted-by":"publisher","first-page":"216305","DOI":"10.1016\/j.canlet.2023.216305","volume":"569","author":"P Zhao","year":"2023","unstructured":"Zhao P, Yuan F, Xu L, Jin Z, Liu Y, Su J et al. HKDC1 reprograms lipid metabolism to enhance gastric cancer metastasis and cisplatin resistance via forming a ribonucleoprotein complex. Cancer Lett 2023;569:216305. https:\/\/doi.org\/10.1016\/j.canlet.2023.216305.","journal-title":"Cancer Lett"},{"key":"10182_CR29","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s41467-024-45712-2","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang M, Ye L, Shen S, Zhang Y, Qian X et al. HKDC1 promotes tumor immune evasion in hepatocellular carcinoma by coupling cytoskeleton to STAT1 activation and PD-L1 expression. Nat Commun 2024;15:1314. https:\/\/doi.org\/10.1038\/s41467-024-45712-2.","journal-title":"Nat Commun"},{"key":"10182_CR30","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/cac2.70022","volume":"45","author":"L J\u00e4rke","year":"2025","unstructured":"J\u00e4rke L, Weber-Stiehl S, Shima K, Moors KA, Genth J, Schuran FA et al. Deletion of epithelial HKDC1 decelerates cellular proliferation and impairs mitochondrial function of tumorous epithelial cells thereby protecting from intestinal carcinogenesis. Cancer Commun (Lond) 2025;45:722\u2013727. https:\/\/doi.org\/10.1002\/cac2.70022.","journal-title":"Cancer Commun (Lond)"},{"key":"10182_CR31","doi-asserted-by":"publisher","first-page":"111929","DOI":"10.1016\/j.mrfmmm.2026.111929","volume":"832","author":"W Feng","year":"2026","unstructured":"Feng W, Wu M, Zou H, Chen Y. The oncogenic role of U2AF2\/HKDC1 cascade in colorectal cancer by promoting cancer cell glycolysis and malignant phenotypes. Mutat Res 2026;832:111929. https:\/\/doi.org\/10.1016\/j.mrfmmm.2026.111929.","journal-title":"Mutat Res"},{"key":"10182_CR32","doi-asserted-by":"publisher","first-page":"148752","DOI":"10.1016\/j.gene.2024.148752","volume":"928","author":"W Yang","year":"2024","unstructured":"Yang W, Lin R, Guan S, Dang Y, He H, Huang X et al. HNF1\u0251 promotes colorectal cancer progression via HKDC1-mediated activation of AKT\/AMPK signaling pathway. Gene 2024;928:148752. https:\/\/doi.org\/10.1016\/j.gene.2024.148752.","journal-title":"Gene"},{"key":"10182_CR33","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/s1470-2045(21)00343-0","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang N, Ng AS, Cai S, Li Q, Yang L, Kerr D. Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer. Lancet Oncol 2021;22:e358\u2013e368. https:\/\/doi.org\/10.1016\/s1470-2045(21)00343-0.","journal-title":"Lancet Oncol"},{"key":"10182_CR34","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1016\/j.cell.2025.08.033","volume":"188","author":"CX Zhang","year":"2025","unstructured":"Zhang CX, Huang RY, Sheng G, Thiery JP. Epithelial-mesenchymal transition. Cell 2025;188:5436\u20135486. https:\/\/doi.org\/10.1016\/j.cell.2025.08.033.","journal-title":"Cell"},{"key":"10182_CR35","doi-asserted-by":"publisher","first-page":"103246","DOI":"10.1016\/j.redox.2024.103246","volume":"75","author":"X Zhang","year":"2024","unstructured":"Zhang X, Chen J, Lin R, Huang Y, Wang Z, Xu S et al. Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la\/KLF5 pathway. Redox Biol 2024;75:103246. https:\/\/doi.org\/10.1016\/j.redox.2024.103246.","journal-title":"Redox Biol"},{"key":"10182_CR36","doi-asserted-by":"publisher","first-page":"101326","DOI":"10.1016\/j.mtbio.2024.101326","volume":"29","author":"J Li","year":"2024","unstructured":"Li J, Ma S, Lin Q, Wang Q, Zhong W, Wei C et al. Orchestrated copper-loaded nanoreactor for simultaneous induction of cuproptosis and immunotherapeutic intervention in colorectal cancer. Mater Today Bio 2024;29:101326. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101326.","journal-title":"Mater Today Bio"},{"key":"10182_CR37","doi-asserted-by":"publisher","first-page":"163582","DOI":"10.1016\/j.cej.2025.163582","volume":"515","author":"J Tang","year":"2025","unstructured":"Tang J, Chen Y, Lai H, Zeng Q, Li Y, Feng J et al. Innovative immunosonogen nanoplatform combining sonodynamic oxygenation and immunomodulation for superior cancer therapy. Chem Eng J 2025;515:163582. https:\/\/doi.org\/10.1016\/j.cej.2025.163582.","journal-title":"Chem Eng J"},{"key":"10182_CR38","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cac2.12414","volume":"43","author":"JW Eun","year":"2023","unstructured":"Eun JW, Yoon JH, Ahn HR, Kim S, Kim YB, Lim SB et al. Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer Commun (Lond) 2023;43:455\u2013479. https:\/\/doi.org\/10.1002\/cac2.12414.","journal-title":"Cancer Commun (Lond)"},{"key":"10182_CR39","doi-asserted-by":"publisher","first-page":"115681","DOI":"10.1016\/j.celrep.2025.115681","volume":"44","author":"J Chen","year":"2025","unstructured":"Chen J, Huang C, Mei J, Lin Q, Chen W, Tang J et al. OTUD4 inhibits ferroptosis by stabilizing GPX4 and suppressing autophagic degradation to promote tumor progression. Cell Rep 2025;44:115681. https:\/\/doi.org\/10.1016\/j.celrep.2025.115681.","journal-title":"Cell Rep"},{"key":"10182_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cancergen.2025.06.006","volume":"296\u2013297","author":"G Jiang","year":"2025","unstructured":"Jiang G, Zhou X, Chen S, Zhong F, Huang G, Wu B et al. SATB2 plays a critical role in pancreatic cancer cell proliferation, migration and T cell cytotoxicity. Cancer Genet 2025;296\u2013297:53\u201364. https:\/\/doi.org\/10.1016\/j.cancergen.2025.06.006.","journal-title":"Cancer Genet"},{"key":"10182_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cancergen.2025.06.008","volume":"296\u2013297","author":"Y Liu","year":"2025","unstructured":"Liu Y, He Q, Zhu L, Zhong M, Zhuang H, Zhao N et al. TRIM29 promotes glioblastoma progression via ubiquitinating NEFL and activating the PI3K\/AKT signaling pathway. Cancer Genet 2025;296\u2013297:88\u201399. https:\/\/doi.org\/10.1016\/j.cancergen.2025.06.008.","journal-title":"Cancer Genet"},{"key":"10182_CR42","doi-asserted-by":"publisher","first-page":"1790936","DOI":"10.3389\/fimmu.2026.1790936","volume":"17","author":"Z Liu","year":"2026","unstructured":"Liu Z, Liu J, Chu H, Lu Z, Xu S, Qin Y et al. JAK inhibition in PD-1 immunotherapy and tumor microenvironment. Front Immunol 2026;17:1790936. https:\/\/doi.org\/10.3389\/fimmu.2026.1790936.","journal-title":"Front Immunol"},{"key":"10182_CR43","doi-asserted-by":"publisher","first-page":"102529","DOI":"10.1016\/j.xcrm.2025.102529","volume":"7","author":"Y Xi","year":"2026","unstructured":"Xi Y, Zhao Z, Zhou Y, Yin C, Li Y, Xu X et al. Macrophage efferocytosis mediated by the TP63-RAC2 pathway promotes immunosuppressive remodeling in esophageal cancer. Cell Rep Med 2026;7:102529. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102529.","journal-title":"Cell Rep Med"},{"key":"10182_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cancergen.2025.04.008","volume":"294\u2013295","author":"H Yin","year":"2025","unstructured":"Yin H, Zhang Z, Zhang Q, You Y, Zhang Z, Han Y et al. PLAU serves as a prognostic biomarker correlated with perineural invasion in HNSCC. Cancer Genet 2025;294\u2013295:145\u2013155. https:\/\/doi.org\/10.1016\/j.cancergen.2025.04.008.","journal-title":"Cancer Genet"},{"key":"10182_CR45","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cancergen.2025.11.007","volume":"298\u2013299","author":"H Zhai","year":"2025","unstructured":"Zhai H, Du Y, He H, Shen X, Hu D. WDR54 enhances NF-kappaB signaling to promote progression of hepatocellular carcinoma. Cancer Genet 2025;298\u2013299:302\u2013314. https:\/\/doi.org\/10.1016\/j.cancergen.2025.11.007.","journal-title":"Cancer Genet"},{"key":"10182_CR46","doi-asserted-by":"publisher","DOI":"10.1109\/JBHI.2026.3672862","author":"H Luo","year":"2026","unstructured":"Luo H, Fan Z, Li W, Liang H, Zhang CJ, Wei X et al. CAMM: confidence-aligned multiview multimodal fusion for brain disorders prediction with imaging transcriptomics. IEEE J Biomed Health Inform. 2026. https:\/\/doi.org\/10.1109\/JBHI.2026.3672862.","journal-title":"IEEE J Biomed Health Inform"},{"key":"10182_CR47","doi-asserted-by":"publisher","first-page":"104059","DOI":"10.1016\/j.media.2026.104059","volume":"111","author":"Z Yang","year":"2026","unstructured":"Yang Z, Zhou Y, Chen H, Zhang H, Zhao D, Wei B et al. UniPET: a universal network for high-quality PET image denoising across varied dose reduction factors. Med Image Anal 2026;111:104059. https:\/\/doi.org\/10.1016\/j.media.2026.104059.","journal-title":"Med Image Anal"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10182-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:08:24Z","timestamp":1789625304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10182-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10182"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10182-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"20 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human participants and animals were approved by the Ethics Committee of the Affiliated Tumor Hospital of Guangxi Medical University (KY20251017, KY20251004). The study was conducted in accordance with the declaration of Helsinki. The research was conducted in compliance with all applicable local regulations and institutional policies. Written informed consent was obtained from each participant prior to their inclusion in the study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}